Factor H

From Wikipedia, the free encyclopedia

Complement factor H
PDB rendering based on 1haq.
Available structures: 2uwn, 2v8e, 2jgx, 2jgw, 1hfi, 1hfh, 1hcc, 2qfh, 2g7i, 2bzm, 1haq
Identifiers
Symbol(s)	CFH; FH; FHL1; ARMD4; ARMS1; CFHL3; HF; HF1; HF2; HUS; MGC88246
External IDs	OMIM: 134370 MGI: 88385 HomoloGene: 20086
Gene ontology Cellular Component: • extracellular space Biological Process: • complement activation, alternative pathway
RNA expression pattern
More reference expression data
Orthologs
	Human	Mouse
Entrez	3075	12628
Ensembl	ENSG00000000971	n/a
Uniprot	P08603	n/a
Refseq	NM_000186 (mRNA) NP_000177 (protein)	XM_001000306 (mRNA) XP_001000306 (protein)
Location	Chr 1: 194.89 - 194.98 Mb	n/a
Pubmed search	[1]	[2]

Factor H is a member of the regulators of complement activation family and is a complement control protein. It is a large (155 kilodalton), soluble glycoprotein that circulates in human plasma (at a concentration of 500-800 micrograms per mL). Its main job is to regulate the Alternative Pathway of the complement system, ensuring that the complement system is directed towards pathogens and does not damage host tissue. Factor H regulates complement activation on self cells by possessing both cofactor activity for Factor I mediated C3b cleavage, and decay accelerating activity against the alternative pathway C3 convertase, C3bBb. Factor H protects self cells from complement activation but not bacteria/viruses, in that it binds to glycosaminoglycans (GAGs) that are present on host cells but not pathogen cell surfaces.

Contents 1 Structure of Factor H 2 Association with age-related macular degeneration 3 Association with atypical Haemolytic Uraemic Syndrome 4 Sources 5 Further reading 6 External links

[edit] Structure of Factor H

The molecule is made up of 20 Complement Control Protein (CCP) modules (also referred to as Short Consensus Repeats or sushi domains) arranged head to tail. Each of the CCP modules consists of around 60 amino acids with four cysteine residues disulfide bonded in a 1-3 2-4 arrangement, and a hydrophobic core built around an almost invariant tryptophan residue. To date atomic structures have been determined for CCPs 1-3, CCP 5, CCP 7 (both 402H & 402Y), CCP 15, CCP 16, CCPs 15-16, and CCPs 19-20. The atomic structure for CCPs 6-8 (402H) bound to the GAG mimic sucrose octasulfate has also been determined. Although an atomic resolution structure for intact factor H has not yet been determined, low resolution techniques indicate that it may be bent back in solution. Information available to date indicates that CCP modules 1-4 is responsible for the cofactor and decay acceleration activities of factor H, whereas self/non-self discrimination occurs predominantly through GAG binding to CCP modules 7 and/or 19-20.

[edit] Association with age-related macular degeneration

Recently is was discovered that about 35% of individuals carry at an at-risk single nucleotide polymorphism (SNP) in one or both copies of their factor H gene. Homozygous individuals have an approximately sevenfold increased chance of developing age-related macular degeneration, while heterozygotes have a two-to-threefold increased likelihood of developing the disease. This SNP, located in CCP module 7 of factor H, has been shown to affect the interactions between factor H and both C-reactive protein and heparin indicating a causal relationship between the SNP and disease.

[edit] Association with atypical Haemolytic Uraemic Syndrome

Haemolytic uraemic syndrome (HUS) is a disease associated with microangiopathic haemolytic anemia, thrombocytopenia and acute renal failure. A rare subset of this disease (referred to as atypical haemolytic uraemic syndrome, aHUS), has been strongly linked to mutations in genes of the complement system (including factor H, factor I and membrane cofactor protein), with the factor H mutations being the most numerous. These factor H mutations tend to congregate towards the C-terminus of factor H - a region responsible for discriminating self from non-self and have been shown to disrupt heparin and C3d binding.

[edit] Sources

• Pangburn, M.K. Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement. Immunopharmacology 49, 149-57 (2000).
• Aslam M. & Perkins S.J. Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling. J Mol Biol. 309(5), 1117-38 (2001).
• Kirkitadze, M.D. & Barlow, P.N. Structure and flexibility of the multiple domain proteins that regulate complement activation. Immunol Rev 180, 146-61 (2001).
• Hageman, G.S. et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102, 7227-32. (2005).
• Kardys, I. et al. A common polymorphism in the complement factor h gene is associated with increased risk of myocardial infarction the rotterdam study. J Am Coll Cardiol. 47, 1568-75. (2006).
• Herbert, A.P. et al. Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism. J Biol Chem. 282(26), 18960-8. (2007).
• Hocking, H.G et al. Structure of the N-terminal region of complment factor H and conformational implications of disease-linked sequence variations. "J Biol Chem" Feb 5 Epub ahead of print (2008).

[edit] Further reading

[edit] External links

• MeSH Complement+Factor+H

v • d • e Proteins: complement system (C, L, A) Activators CLA: C3-convertase - C5-convertase - MAC (C6, C7, C8, C9) - L: Mannan-binding lectin - A: Factor P/Properdin Enzymes C: C1Q/C1R/C1S - C4 (C4a) - C2 - CLA: C3 (C3a, C3b/iC3b) - C5 (C5a) - L: MASP1 - MASP2 - A: Complement factor B - Factor D Inhibitors CLA: C1-inhibitor - Decay accelerating factor - Factor I - CL: C4BP - A: Factor H Complement receptors CR1 - CR2 - CR3 - CR4 - CD11b/CD11c/CD18 - Anaphylatoxin (C3a, C5a)

v • d • e Globulins: beta globulins Angiostatin - Haemopexin - Beta-2 microglobulin - Factor H - Plasminogen - Properdin - Sex hormone binding globulin - Transferrin